Mutual Advisors LLC Has $796,000 Position in Intuitive Surgical, Inc. $ISRG

Mutual Advisors LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.7% during the second quarter, Holdings Channel reports. The fund owned 1,605 shares of the medical equipment provider’s stock after buying an additional 86 shares during the quarter. Mutual Advisors LLC’s holdings in Intuitive Surgical were worth $796,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of ISRG. Nuveen LLC acquired a new position in shares of Intuitive Surgical during the 1st quarter valued at $1,715,899,000. Goldman Sachs Group Inc. raised its holdings in Intuitive Surgical by 26.1% during the first quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider’s stock worth $1,396,496,000 after buying an additional 584,375 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Intuitive Surgical by 20.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock worth $1,680,922,000 after buying an additional 566,979 shares during the last quarter. Wellington Management Group LLP raised its holdings in Intuitive Surgical by 15.0% during the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after buying an additional 457,080 shares during the last quarter. Finally, Vanguard Group Inc. raised its holdings in Intuitive Surgical by 1.4% during the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after buying an additional 453,335 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have weighed in on ISRG shares. Piper Sandler restated an “overweight” rating and set a $595.00 price objective (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a report on Wednesday, October 8th. Evercore ISI lowered their price objective on shares of Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating on the stock in a report on Tuesday, October 7th. BTIG Research lowered their price objective on shares of Intuitive Surgical from $571.00 to $529.00 and set a “buy” rating on the stock in a report on Monday, October 13th. Finally, Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday. Fourteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $580.29.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $446.13 on Friday. The firm has a 50-day moving average of $454.97 and a 200-day moving average of $495.75. The company has a market cap of $159.93 billion, a P/E ratio of 62.22, a P/E/G ratio of 4.69 and a beta of 1.61. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm’s revenue for the quarter was up 21.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.78 earnings per share. As a group, research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In related news, Director Amy L. Ladd sold 336 shares of the stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares in the company, valued at approximately $504,898.14. This represents a 23.83% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Myriam Curet sold 4,500 shares of the stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares of the company’s stock, valued at approximately $173,845.44. The trade was a 92.73% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.